[
  {
    "ts": null,
    "headline": "AtriCure (ATRC) Tops Q4 Earnings and Revenue Estimates",
    "summary": "AtriCure (ATRC) delivered earnings and revenue surprises of +400.00% and +0.01%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=b90df921f87aaa8eb620b56b8cc5cf82946ee95a14f00daf8bc10d254ac52eac",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771367701,
      "headline": "AtriCure (ATRC) Tops Q4 Earnings and Revenue Estimates",
      "id": 139127475,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "AtriCure (ATRC) delivered earnings and revenue surprises of +400.00% and +0.01%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=b90df921f87aaa8eb620b56b8cc5cf82946ee95a14f00daf8bc10d254ac52eac"
    }
  },
  {
    "ts": null,
    "headline": "Insulet Corp (NASDAQ:PODD): A Prime GARP Candidate in Diabetes Care",
    "summary": "Insulet Corp (PODD) is a top GARP stock, showing strong double-digit growth in diabetes care at a valuation reasonable for its industry and growth trajectory.",
    "url": "https://finnhub.io/api/news?id=7ec6d632547cbbf75ec26c74e2b486f9f3e31b11084ed48f29f1d20f0f5d0ef7",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771335659,
      "headline": "Insulet Corp (NASDAQ:PODD): A Prime GARP Candidate in Diabetes Care",
      "id": 139121870,
      "image": "https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp",
      "related": "PODD",
      "source": "ChartMill",
      "summary": "Insulet Corp (PODD) is a top GARP stock, showing strong double-digit growth in diabetes care at a valuation reasonable for its industry and growth trajectory.",
      "url": "https://finnhub.io/api/news?id=7ec6d632547cbbf75ec26c74e2b486f9f3e31b11084ed48f29f1d20f0f5d0ef7"
    }
  },
  {
    "ts": null,
    "headline": "Earnings To Watch: Insulet (PODD) Reports Q4 Results Tomorrow",
    "summary": "Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Wednesday morning. Here’s what to look for.",
    "url": "https://finnhub.io/api/news?id=c2eb041ed701749ac7aabd2470e525b5d01be4afe9eedfcdb95237073bdee1d9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771297450,
      "headline": "Earnings To Watch: Insulet (PODD) Reports Q4 Results Tomorrow",
      "id": 139119337,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Wednesday morning. Here’s what to look for.",
      "url": "https://finnhub.io/api/news?id=c2eb041ed701749ac7aabd2470e525b5d01be4afe9eedfcdb95237073bdee1d9"
    }
  }
]